PARP1 and neoplasm: This is an example of a ‘synthetic lethality’, so-called because it results from the cumulative effects of losing two complementary repair pathways simultaneously; similar effects involving PARP inhibition in conjunction with other tumour-associated repair defects have also been found (7,8).